PolyPid (PYPD) EBITDA (2019 - 2026)

PolyPid has disclosed EBITDA across 8 years of filings, most recently posting $7.8 million for Q2 2026.

• In Q2 2026, EBITDA fell 16.53% year-over-year to $7.8 million; the TTM figure through Jun 2026 stood at $31.6 million (down 3.05% YoY), while the FY2025 annual figure was $33.0 million, up 17.62% from the prior year.
• EBITDA came in at $7.8 million for Q2 2026 at PolyPid, up from $7.8 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $12.0 million in Q1 2022 to a low of $5.3 million in Q3 2023.
• Average EBITDA over 5 years is $7.7 million, with a median of $7.5 million recorded in 2025.
• Year-over-year, EBITDA tumbled 51.57% in 2022 and surged 53.62% in 2025.
• Over 5 years, EBITDA stood at $6.6 million in 2022, then retreated by 9.27% to $6.0 million in 2023, then soared by 37.04% to $8.2 million in 2024, then climbed by 3.76% to $8.5 million in 2025, then retreated by 7.98% to $7.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $7.8 million in Q2 2026, $7.8 million in Q1 2026, and $8.5 million in Q4 2025.